Professional Marketing briefs: June 2013

Share this article:
Professional Marketing briefs: June 2013
Professional Marketing briefs: June 2013

Pfizer told investors at its first-quarter marketing call that a Xeljanz DTC marketing campaign is in the works for summer and that its promotional efforts among physicians—including 28-day sample packs and sales reps—has resulted in repeat prescriptions and pickup among post-methotrexate and anti-TNF patients. The company also said the drug has had broader reimbursement than anticipated.

Amgen reached a $25 million settlement with the U.S government for marketing practices around its anemia drug Aranesp. Allegations include kickbacks to long-term care pharmacies to favor Aranesp over other treatments as well as for off-label indications. The Department of Justice alleged that Amgen offered rebates for pharmacies which helped to improve Aranesp's market share.

Eli Lilly and Merck will put more person-to-person sales power behind their diabetes franchises. Lilly stated its intent before releasing its first-quarter earnings report, in tandem with an announcement that it was cutting sales support for Cymbalta and Evista. Merck has decided more of its US reps need to be dedicated only to Januvia, which saw sales slide 4% during the quarter.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Agency Gallery

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Agency Gallery

Agency Business briefs: June 2014

Agency Business briefs: June 2014

News on Publicis, Palio+Ignite, PulseCX, McCann HumanCare and GolinHarris

It's time to replace the FDA, says Newt Gingrich

It's time to replace the FDA, says Newt ...

Former Speaker of the House and presidential candidate Newt Gingrich has declared that it's time to replace FDA

Agency Business briefs: May 2014

Agency Business briefs: May 2014

Newson ID Media, Frontline Medical Communications and ContextMedia